[The use of sibicort in the combined therapy of patients with eczema, neurodermatitis and allergic dermatitis].
The authors assess the clinical efficacy of sibicort, and ointment manufactured by Orion, Finland, used in therapy of patients suffering from neurodermatitis, eczema, and allergic dermatitis. Pathogenetic treatment combined with sibicort has been administered to 64 patients with disseminated true eczema, 115 ones with diffuse neurodermatitis, and 20 ones with allergic dermatitis. The ointment has been applied to and a little bit rubbed in the foci of lesions twice a day. Sibicort has proved to be a highly effective external drug for the treatment of allergic itching dermatoses. Both immediate and late results have been the best in neurodermatitis patients. No side effects or complications associated with this ointment application have been observed; the drug has been well tolerated.
Iagovdik
N Z
NZ
Kachuk
M V
MV
Politov
V F
VF
D000293:Adolescent; D000328:Adult; D003131:Combined Modality Therapy; D003876:Dermatitis, Atopic / Q000628:therapy*; D004485:Eczema / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009450:Neurodermatitis / Q000628:therapy*; D009824:Ointments / Q000627:therapeutic use*
D009824:Ointments
Primenenie sibikorta v kompleksnoĭ terapii bol'nykh ékzemoĭ, neĭrodermitom i allergicheskim dermatitom.